Cordlife Group Limited (SGX:P8A)

Market Cap	58.95M
Revenue (ttm)	37.64M
Net Income (ttm)	-11.13M
Shares Out	256.31M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	12,700
Open	0.2100
Previous Close	0.2100
Day's Range	0.2100 - 0.2100
52-Week Range	0.1310 - 0.3300
Beta	0.77
RSI	45.58
Earnings Date	Nov 10, 2025

About Cordlife Group

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test ...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 2001
• Employees: 538
• Stock Exchange: Singapore Exchange
• Ticker Symbol: P8A